|
|
Changes of Intestinal Microecology and Immune Function in Children before and after Helicobacter Pylori Eradication Treatment |
LYU Rong-fen, HU Jun-wei |
Department of Neonatology, Fufeng County People's Hospital, Baoji 722299 |
|
|
Abstract 【Objective】To explore the changes of intestinal microecology and immune function in children before and after Helicobacter pylori (Hp) eradication treatment. 【Methods】The clinical data of 91 children with HP infection admitted to the hospital from September 2017 to March 2020 were retrospectively analyzed. All children were treated with a quadruple standardized radical cure for HP infection. The changes of intestinal microecology and immune function in children before and after eradication treatment were compared. Drug safety was evaluated. 【Results】After treatment, the proportion of Escherichia coli, Enterococcus, Clostridium, and Parabacteroides was higher than before treatment (P<0.05), The proportion of Pretotella, Bifidobacterium, Lactobacillus, Koala, Bacteroides was lower than before treatment (P<0.05). CD3+, CD4+ and CD4+/CD8+ levels after treatment were higher than those before treatment (P<0.05), while CD8+ level after treatment was lower than before treatment (P<0.05). The levels of IgA, IgM and IgG after treatment in children were higher than before treatment (P<0.05). The children had no obvious adverse reactions, and the safety was good during the treatment. 【Conclusion】The structure of the intestinal flora changes in children with Hp infection after eradication treatment, which can effectively improve their immune function.
|
Received: 04 November 2020
|
|
|
|
|
[1] CHOI I J, KOOK M C, KIM Y I, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer[J].N Engl J Med,2018, 378(12):1085-1095. [2] 赵改仙, 连红梅, 阎小宁. 幽门螺杆菌感染与肝硬化患者上消化道出血及肝性脑病的关系[J].海南医学, 2019, 30(21):2755-2757. [3] 高新基, 王君, 李强,等. 胃微生物菌群与幽门螺杆菌感染的胃贲门腺癌发病相关性分析[J].中国微生态学杂志, 2019, 31(2):79-83. [4] 邹艳, 詹孔才, 吴明德. 肠道菌群检测对溃疡性结肠炎患者肠黏膜内炎症反应、免疫应答的评估价值[J].海南医学院学报, 2017, 5(18):2484-2487. [5] GONG Y, YUAN Y. Resistance mechanisms of Helicobacter pylori and its dual target precise therapy[J].Crit Rev Microbiol,2018, 44(3):371-392. [6] 于佳鹭, 李在玲. 儿童幽门螺杆菌根除治疗过程中肠道菌群的变化[J].临床儿科杂志, 2020, 38(6):426-430. [7] 陆冰云, 陈 烨. 雷贝拉唑四联根除幽门螺杆菌感染对肠道微生态影响[J].临床军医杂志, 2018, 46(6):639-641. [8] 唐源淋, 陈 烨. 定量分析幽门螺杆菌根除前后部分肠道菌群的改变[J].胃肠病学, 2020, 25(1):18-22. [9] 朱虹,时昭红,张书,等.含铋剂四联疗法对幽门螺旋杆菌感染患者血清炎性因子及免疫功能的影响[J].中华医院感染学杂志,2020,30(1):77-81. |
|
|
|